Skip to main content

Robin Schmitz, MD

House Staff
Start Year: 
2017
College/University: 
Heidelberg University
Medical School: 
Heidelberg University School of Medicine

Clinical and Research Interests

  • Hepatobiliary and pancreatic surgery
  • Transplant surgery
  • Surgical oncology

What were you looking for in a residency program?

The combination of world-class surgical education and research opportunities

What are the strengths of the Duke program?

Combining clinical excellence with state-of-the-art research 

Publications

Schmitz, Robin, Dimitrios Moris, John H. Strickler, and Dan G. Blazer. “ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas.” Ann Surg Oncol, July 1, 2020. https://doi.org/10.1245/s10434-020-08802-1.

Full Text

Schmitz, Robin, Rui Mao, Dimitrios Moris, John H. Strickler, and Dan G. Blazer. “Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma.” Ann Surg Oncol, June 18, 2020. https://doi.org/10.1245/s10434-020-08730-0.

Full Text

Schmitz, Robin, Mohamed A. Adam, and Dan G. Blazer. “Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.” World J Surg Oncol 17, no. 1 (November 4, 2019): 180. https://doi.org/10.1186/s12957-019-1728-z.

Full Text